Biosyent Inc
XTSX:RX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biosyent Inc
XTSX:RX
|
CA |
|
Beneteau SA
PAR:BEN
|
FR |
Wall Street
Price Targets
RX Price Targets Summary
Biosyent Inc
According to Wall Street analysts, the average 1-year price target for
RX
is 16.83 CAD
with a low forecast of 16.67 CAD and a high forecast of 17.33 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RX's stock price target?
Price Target
16.83
CAD
According to Wall Street analysts, the average 1-year price target for
RX
is 16.83 CAD
with a low forecast of 16.67 CAD and a high forecast of 17.33 CAD.
What is Biosyent Inc's Revenue forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Biosyent Inc's revenue is
21%.
The projected
CAGR
for the next 3 years is
12%.
What is Biosyent Inc's Operating Income forecast?
Projected CAGR
-9%
For the last 13 years the
compound annual growth rate for
Biosyent Inc's operating income is
26%.
The projected
CAGR
for the next 5 years is
-9%.
What is Biosyent Inc's Net Income forecast?
Projected CAGR
15%
For the last 13 years the
compound annual growth rate for
Biosyent Inc's net income is
25%.
The projected
CAGR
for the next 3 years is
15%.
